Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair Diskus plus Spiriva HandiHaler in COPD
NCT00784550Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Dec 2008; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00784550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784550.